NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.

Nanjing Well Pharmaceutical Group Co.,Ltd.

Equities

603351

CNE100003JD4

Oil & Gas Refining and Marketing

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
20.26 ^CNY	-2.36%		-1.07%	-23.17%

04-25	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Nanjing Well Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2019, Payable on May 27, 2020

May 19, 2020

Nanjing Well Pharmaceutical Co. Ltd. announced cash dividend of RMB 0.6 (taxes included) per A share for the year 2019. Record date is May 26, 2020 and ex-right and ex-dividend date is May 27, 2020. Cash dividend payable date is May 27, 2020.

Latest news about Nanjing Well Pharmaceutical Group Co.,Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. completed the acquisition of13% stake in Nanjing Xingwei Biotechnology Co., Ltd. from Wu Renrong, Gao Zhengsong, Chen Xinguo, Tang Qunsong, Shen Jiusi, Wu Rongwen, Hong Shilin, Zou Jianguo, Wang Fuqiu and Zhou Chong.	16/08/23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. signed an agreement to acquire 13% stake in Nanjing Xingwei Biotechnology Co., Ltd. from Wu Renrong, Gao Zhengsong, Chen Xinguo, Tang Qunsong, Shen Jiusi, Wu Rongwen, Hong Shilin, Zou Jianguo, Wang Fuqiu and Zhou Chong for CNY0.	16/08/23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/04/23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	18/04/22	CI
Certain A Shares of Nanjing Well Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-JAN-2022.	29/01/22	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/07/21	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	26/04/21	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	12/04/21	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	23/10/20	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	19/08/20	CI
Nanjing Well Pharmaceutical Group Co.,Ltd.(XSSC:603351) dropped from S&P Global BMI Index	22/06/20	CI
Nanjing Well Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2019, Payable on May 27, 2020	19/05/20	CI
Nanjing Well Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	27/04/20	CI
Nanjing Market Supervision and Administration Bureau has Changed its Name to Nanjing Well Pharmaceutical Co.,Ltd	22/04/20	CI
Nanjing Well Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20/04/20	CI
Certain A Shares of Nanjing Well Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-JAN-2020.	29/01/20	CI
Nanjing Well Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	28/10/19	CI

Chart Nanjing Well Pharmaceutical Group Co.,Ltd.

Duration

Period

Chart Nanjing Well Pharmaceutical Group Co.,Ltd.

More charts

Company Profile

Nanjing Well Pharmaceutical Group Co Ltd, formerly Nanjing Well Pharmaceutical Co Ltd, is a China-based company principally involved in the research and development, manufacturing and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil products. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The Company distributes its products primarily in domestic market.

Sector

Oil & Gas Refining and Marketing

Calendar

19/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Oil & Gas Refining and Marketing

	1st Jan change	Capi.
NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.	-23.17%	387M
RELIANCE INDUSTRIES LTD	+18.42%	245B
CHINA PETROLEUM & CHEMICAL CORPORATION	+20.78%	98.02B
BP PLC	+1.43%	96.62B
MARATHON PETROLEUM CORPORATION	+16.55%	61.41B
PHILLIPS 66	+4.70%	59.26B
VALERO ENERGY CORPORATION	+18.49%	50.22B
IMPERIAL OIL LIMITED	+25.17%	36.41B
INDIAN OIL CORPORATION LIMITED	+25.98%	27.07B
REPSOL S.A.	+8.85%	19.05B

Other Oil & Gas Refining and Marketing